Please assess the completion status of the following clinical trial:

Trial Title: Cardiomyopathy in DMD: Lisinopril vs. Losartan

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Duchenne muscular dystrophy patients of all ages~* Null mutation of the dystrophin gene or muscle with \<5% dystrophin~* Doppler echocardiogram with ejection fraction (EF) \<55% within 30 days of enrollment~* Ability to cooperate for testing~* Glucocorticoid treatment acceptable including daily or weekend administration of prednisone or deflazacort~Exclusion Criteria:~* Patients with EF 55% or greater~* Patients with EF \<40% after washout~* Patients taking \>5 mg lisinopril, or \>25 mg losartan or \>5 mg enalapril~* Skeletal deformities or pulmonary anatomical variants that preclude consistent measures of Doppler echocardiography

- Gender: MALE
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Lisinopril (Type: ACTIVE_COMPARATOR): None
- Losartan (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).